Cargando…
Effect size of rituximab on pulmonary function in the treatment of connective-tissue disease-related interstitial lung disease: a systematic review and meta-analysis
BACKGROUND: Rituximab (RTX) has been previously reported as directed treatment in patients with connective-tissue disease-related interstitial lung diseases (CTD-ILD). A systematic assessment of treatment effect size on pulmonary function outcomes and related adverse effects in patients with CTD-ILD...
Autores principales: | Zhao, Yuanchen, Gao, Yang, Petnak, Tananchai, Cheungpasitporn, Wisit, Thongprayoon, Charat, Zhang, Xing, Moua, Teng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215101/ https://www.ncbi.nlm.nih.gov/pubmed/35729565 http://dx.doi.org/10.1186/s12931-022-02082-x |
Ejemplares similares
-
Impact of Antifibrotic Treatment on Postoperative Complications in Patients with Interstitial Lung Diseases Undergoing Lung Transplantation: A Systematic Review and Meta-Analysis
por: Taweesedt, Pahnwat, et al.
Publicado: (2023) -
Serum Chloride Levels at Hospital Discharge and One-Year Mortality among Hospitalized Patients
por: Petnak, Tananchai, et al.
Publicado: (2020) -
Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis
por: Hansrivijit, Panupong, et al.
Publicado: (2020) -
Association of Serum Phosphate Derangement With Mortality in Patients
on Continuous Renal Replacement Therapy
por: Thongprayoon, Charat, et al.
Publicado: (2022) -
Acute Myocardial Infarction among Hospitalizations for Heat Stroke in the United States
por: Bathini, Tarun, et al.
Publicado: (2020)